FDA Panel Votes to Approve Duloxetine for Lower Back Pain

EGMN -- In a split vote, a Food and Drug Administration advisory panel voted 8-6 that the approved pain indications for duloxetine be expanded to include a broader population of patients with chronic pain, at a meeting on August 19.